fabrizio De Benedetti

Head

Ospedale Pediatrico Bambino Gesù

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Fabrizio De Benedetti is the Head at Ospedale Pediatrico Bambino Gesù in Italy. His research focuses primarily on Still's disease, macrophage activation syndrome, and juvenile idiopathic arthritis, as evidenced by his recent publications, which inform guidelines and recommendations in these areas. His work includes systematic reviews, clinical trials, and studies related to the efficacy and safety of various therapeutic interventions.

Articles (12)

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (5)

Grant Schulert

Assistant Professor

University of Cincinnati College of Medicine

UNITED STATES

View details

Peggy Jacques

professor

Ghent University

BELGIUM

View details

Sergio Ghirardo

University of Trieste

ITALY

View details

Pedro Saavedra

Assistant Professor

Northeastern University

UNITED STATES

View details

Yukiko Kimura

Hackensack University Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

fabrizio De Benedetti

Research Interests

Explore related searches

Contact this professor

About

Articles (12)

Long‐Term Efficacy and Safety of Canakinumab in Patients With Tumor Necrosis Factor Receptor–Associated Periodic Syndrome: Results From a Phase III Trial

Efficacy and safety of therapies for Still's disease and macrophage activation syndrome (MAS): a systematic review informing the EULAR/PReS guidelines for the management of Still's disease

Systemic juvenile idiopathic arthritis and adult-onset Still's disease are the same disease: evidence from systematic reviews and meta-analyses informing the 2023 EULAR/PReS recommendations for the diagnosis and management of Still's disease

Efficacy and safety of emapalumab in macrophage activation syndrome

Targeting interferon-γ in hyperinflammation: opportunities and challenges

Functional Ability and Health‐Related Quality of Life in Randomized Controlled Trials of Tocilizumab in Patients With Juvenile Idiopathic Arthritis

Blood-based test for diagnosis and functional subtyping of familial Mediterranean fever

A rare cause of multiple airways narrowing in a 15-year-old girl

<p>Dynamic Contrast-Enhanced MRI Confirms Rapid And Sustained Improvement Of Rheumatoid Arthritis Induced By Tocilizumab Treatment: An Italian Multicentre Study</p>

A RANDOMIZED, PLACEBO-CONTROLLED STUDY OF ANAKINRA IN PATIENTS WITH STILL ' S DISEASE

A patient with stimulator of interferon genes-associated vasculopathy with onset in infancy without skin vasculopathy

An inflammatory profile correlates with decreased frequency of cytotoxic cells in coronavirus disease 2019

Collaborators (5)

Grant Schulert

Peggy Jacques

Sergio Ghirardo

Pedro Saavedra

Yukiko Kimura

Make your next move.